Ribavirin for Hepatitis E Virus Infection After Organ Transplantation

Autor: Kamar, Nassim, Legrand-Abravanel, Florence, Behrendt, Patrick, Hofmann, Jörg, Pageaux, Georges Phillippe, Barbet, Christelle, Moal, Valerie, Couzi, Lionel, Horvatits, Thomas, de Man, Robert, Cassuto, Elisabeth, Elsharkawy, Ahmed, Riezebos-Brilman, Annelies, Scemla, Anne, Hillaire, Sophie, Donnelly, Mhairi, Radenne, Sylvie, Sayegh, Johnny, Garrouste, Cyril, Dumortier, Jérôme, Glowaki, François, Matignon, Marie, Coilly, Audrey, Figueres, Lucile, Mousson, Christiane, Minello, Anne, Dharancy, Sébastien, Rerolle, Jean Philippe, Lebray, Pascal, Etienne, Isabelle, Perrin, Peggy, Choi, Mira, Olivier, Marion, Izopet, Jacques, Bellière, J, Cointault, O., del Bello, Arnaud, Espostio, L, Hebral, A, Lavayssière, L, Lhomme, S, Mansuy, J, Wedemeyer, H, Nickel, P, Bismuth, M., Stefic, K, Buchler, M., D’alteroche, L, Colson, P., Bufton, S, Ramière, C, Trimoulet, P., Pischke, S, Todesco, E, Sberro Soussan, R, Legendre, C, Mallet, V., Johannessen, I, Simpson, K

Publikováno v: Clinical Infectious Diseases
Clinical Infectious Diseases, Oxford University Press (OUP), 2020, 71 (5), pp.1204-1211. ⟨10.1093/cid/ciz953⟩
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71(5), 1204-1211. Oxford University Press
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
United States
Clinical Infectious Diseases, 71(5), 1204-1211. Oxford University Press
Clinical Infectious Diseases, Oxford University Press (OUP), 2019, ⟨10.1093/cid/ciz953⟩
Clinical Infectious Diseases, 2020, 71 (5), pp.1204-1211. ⟨10.1093/cid/ciz953⟩

Background Ribavirin is currently recommended for treating chronic hepatitis E virus (HEV) infection. This retrospective European multicenter study aimed to assess the sustained virological response (SVR) in a large cohort of solid organ transplant (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9291b965e91f3ecf369fd895a0047810
https://hal-amu.archives-ouvertes.fr/hal-02465266

Chronic Hepatitis E in Rheumatology and Internal Medicine Patients: A Retrospective Multicenter European Cohort Study

Autor: Pischke, Sven, Peron, Jean-Marie, von Wulffen, Moritz, von Felden, Johann, Höner zu Siederdissen, Christoph, Fournier, Sophie, Lütgehetmann, Marc, Iking-Konert, Christoph, Bettinger, Dominik, Par, Gabriella, Thimme, Robert, Cantagrel, Alain, Lohse, Ansgar, Wedemeyer, Heiner, de Man, Robert, Mallet, Vincent

Publikováno v: Viruses
Viruses, 2019, 11 (2), pp.186. ⟨10.3390/v11020186⟩

International audience; Objectives: Hepatitis E virus (HEV) infection is a pandemic with regional outbreaks, including in industrialized countries. HEV infection is usually self-limiting but can progress to chronic hepatitis E in transplant recipient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1398::a8a9ecf477e1ff76e5b71569df9798af
https://ut3-toulouseinp.hal.science/hal-03597418/document

Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients

Autor: Nassim Kamar, Laurence Lavayssière, Anne Laure Hebral, Olivier Marion, Jacques Izopet, Olivier Cointault, Laure Esposito, Sébastien Lhomme, David Ribes, Arnaud Del Bello, Florence Abravanel

Publikováno v: Journal of Hepatology
Journal of Hepatology, 2019, 70 (1), pp.206-214. ⟨10.1016/j.jhep.2018.09.011⟩

International audience; Hepatitis E virus genotype 3 (HEV3) and 4 (HEV4) can progress to chronic hepatitis in immunosuppressed patients.1 Ribavirin therapy has been shown to be efficient for treating chronic HEV infection in solid-organ-transplant re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08fefcd9d62ea9f71744877fdd80ee07
https://ut3-toulouseinp.hal.science/hal-03602075

Chronic Hepatitis E in Rheumatology and Internal Medicine Patients

Autor: Alain Cantagrel, Christoph Höner zu Siederdissen, Sven Pischke, Marc Lütgehetmann, Ansgar W. Lohse, Jean-Marie Peron, Heiner Wedemeyer, Christoph Iking-Konert, Vincent Mallet, Robert Thimme, Robert A. de Man, Dominik Bettinger, Johann von Felden, Moritz von Wulffen, Sophie Fournier, Gabriella Pár

Publikováno v: Viruses
Volume 11
Issue 2
Viruses, Vol 11, Iss 2, p 186 (2019)
Viruses, 2019, 11 (2), pp.186. ⟨10.3390/v11020186⟩

Objectives: Hepatitis E virus (HEV) infection is a pandemic with regional outbreaks, including in industrialized countries. HEV infection is usually self-limiting but can progress to chronic hepatitis E in transplant recipients and HIV-infected patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88c43771bbc3a7cf76dc0c64ac6b7258
https://doi.org/10.3390/v11020186

Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV

Autor: Matthew L. Albert, M. Ahloulay, Hala Mansour, Vincent Mallet, Cyril Lababidi, Jérémie Decalf, Estelle Mottez, James Mapes, Armanda Casrouge, Arnaud Fontanet, Anaïs Vallet-Pichard, Stanislas Pol

Publikováno v: Journal of Clinical Investigation
Journal of Clinical Investigation, American Society for Clinical Investigation, 2011, 121 (1), pp.308-17. 〈10.1172/JCI40594〉
Journal of Clinical Investigation, American Society for Clinical Investigation, 2011, 121 (1), pp.308-17. ⟨10.1172/JCI40594⟩
Journal of Clinical Investigation, 2011, 121 (1), pp.308-17. ⟨10.1172/JCI40594⟩

International audience; Chronic infection with hepatitis C virus (HCV) is a major public health problem, with nearly 170 million infected individuals worldwide. Current treatment for chronic infection is a combination of pegylated IFN-α2 and ribavir

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b85bf52b527cfbc3f8ad84af20ca5e8